Daniel Ontaneda Department of Biomedical Engineering, Lerner Research Institute Cleveland Clinic Biography Publications Institution JoVE Articles Daniel Ontaneda has not added a biography. If you are Daniel Ontaneda and would like to personalize this page please email our Author Liaison for assistance. Publications Exploratory MRI Measures After Intravenous Autologous Culture-expanded Mesenchymal Stem Cell Transplantation in Multiple Sclerosis Multiple Sclerosis Journal - Experimental, Translational and Clinical. Apr-Jun, 2019 | Pubmed ID: 31236284 MOG-related Disorders: A New Cause of Imaging-negative Myelitis? Multiple Sclerosis (Houndmills, Basingstoke, England). Apr, 2019 | Pubmed ID: 30931813 Imaging Outcome Measures of Neuroprotection and Repair in MS: A Consensus Statement from NAIMS Neurology. Mar, 2019 | Pubmed ID: 30787160 MS Progression is Predominantly Driven by Age-related Mechanisms - NO Multiple Sclerosis (Houndmills, Basingstoke, England). Jun, 2019 | Pubmed ID: 30747571 Multiple Sclerosis Risk Factors Contribute to Onset Heterogeneity Multiple Sclerosis and Related Disorders. Feb, 2019 | Pubmed ID: 30529925 Comparative Effectiveness of Dimethyl Fumarate Versus Fingolimod and Teriflunomide Among MS Patients Switching from First-generation Platform Therapies in the US Multiple Sclerosis and Related Disorders. Jan, 2019 | Pubmed ID: 30368221 Clinical Commentary on "Warts and All: Fingolimod and Unusual HPV Associated Lesions" Multiple Sclerosis (Houndmills, Basingstoke, England). Nov, 2018 | Pubmed ID: 30427261 Treatment Decisions in MS: Shifting the Goal Posts or Changing How We See Them? Multiple Sclerosis (Houndmills, Basingstoke, England). 10, 2018 | Pubmed ID: 30234433 Identifying a New Subtype of Multiple Sclerosis Neurodegenerative Disease Management. 12, 2018 | Pubmed ID: 30215581 Automated Integration of Multimodal MRI for the Probabilistic Detection of the Central Vein Sign in White Matter Lesions AJNR. American Journal of Neuroradiology. Oct, 2018 | Pubmed ID: 30213803 Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis The New England Journal of Medicine. 08, 2018 | Pubmed ID: 30157388 Cortical Neuronal Densities and Cerebral White Matter Demyelination in Multiple Sclerosis: a Retrospective Study The Lancet. Neurology. 10, 2018 | Pubmed ID: 30143361 Discontinuation and Comparative Effectiveness of Dimethyl Fumarate and Fingolimod in 2 Centers Neurology. Clinical Practice. Aug, 2018 | Pubmed ID: 30140580 Stem Cell Injection-induced Glioneuronal Lesion of the Cauda Equina Neurology. Mar, 2018 | Pubmed ID: 29476035 Diagnostic Performance of Central Vein Sign for Multiple Sclerosis with a Simplified Three-lesion Algorithm Multiple Sclerosis (Houndmills, Basingstoke, England). 05, 2018 | Pubmed ID: 28820013 Treating Primary-progressive Multiple Sclerosis: Potential of Ocrelizumab and Review of B-cell Therapies Degenerative Neurological and Neuromuscular Disease. 2017 | Pubmed ID: 30050376 Clinical Outcome Measures for Progressive MS Trials Multiple Sclerosis (Houndmills, Basingstoke, England). Oct, 2017 | Pubmed ID: 29041863 The Challenges and Opportunities of Multiple Sclerosis Care in Latin America Multiple Sclerosis Journal - Experimental, Translational and Clinical. Jul-Sep, 2017 | Pubmed ID: 28979792 Comparative Efficacy and Discontinuation of Dimethyl Fumarate and Fingolimod in Clinical Practice at 24-month Follow-up Multiple Sclerosis Journal - Experimental, Translational and Clinical. Jul-Sep, 2017 | Pubmed ID: 28890796 T1-/T2-weighted Ratio Differs in Demyelinated Cortex in Multiple Sclerosis Annals of Neurology. Oct, 2017 | Pubmed ID: 28833377 The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. Oct, 2017 | Pubmed ID: 28770481 Smokers with MS Have Greater Decrements in Quality of Life and Disability Than Non-smokers Multiple Sclerosis (Houndmills, Basingstoke, England). Nov, 2017 | Pubmed ID: 28059618 Progressive Multiple Sclerosis: Prospects for Disease Therapy, Repair, and Restoration of Function Lancet (London, England). 04, 2017 | Pubmed ID: 27889191 Inadequate Outcome Measures Are the Biggest Impediment to Successful Clinical Trials in Progressive MS - Commentary Multiple Sclerosis (Houndmills, Basingstoke, England). 04, 2017 | Pubmed ID: 27729553 Imaging As an Outcome Measure in Multiple Sclerosis Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. 01, 2017 | Pubmed ID: 27699722 Measuring Brain Tissue Integrity During 4 Years Using Diffusion Tensor Imaging AJNR. American Journal of Neuroradiology. Jan, 2017 | Pubmed ID: 27659189 Comparative Efficacy and Discontinuation of Dimethyl Fumarate and Fingolimod in Clinical Practice at 12-month Follow-up Multiple Sclerosis and Related Disorders. Nov, 2016 | Pubmed ID: 27919497 The Central Vein Sign and Its Clinical Evaluation for the Diagnosis of Multiple Sclerosis: a Consensus Statement from the North American Imaging in Multiple Sclerosis Cooperative Nature Reviews. Neurology. Dec, 2016 | Pubmed ID: 27834394 Heterogeneous Depression Trajectories in Multiple Sclerosis Patients Multiple Sclerosis and Related Disorders. Sep, 2016 | Pubmed ID: 27645367 Design, Rationale, and Baseline Characteristics of the Randomized Double-blind Phase II Clinical Trial of Ibudilast in Progressive Multiple Sclerosis Contemporary Clinical Trials. 09, 2016 | Pubmed ID: 27521810 Relapse Rates in Patients with Multiple Sclerosis Treated with Fingolimod: Subgroup Analyses of Pooled Data from Three Phase 3 Trials Multiple Sclerosis and Related Disorders. Jul, 2016 | Pubmed ID: 27456887 Propensity Methods for Multiple Sclerosis: The Devil is in the Details Multiple Sclerosis (Houndmills, Basingstoke, England). 09, 2016 | Pubmed ID: 27411702 Camptocormia and Pisa Syndrome As Manifestations of Acute Myasthenia Gravis Exacerbation Journal of the Neurological Sciences. Dec, 2015 | Pubmed ID: 26671078 Risk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple Sclerosis CNS Drugs. Sep, 2015 | Pubmed ID: 26407624 Progressive Multiple Sclerosis Current Opinion in Neurology. Jun, 2015 | Pubmed ID: 25887766 Clinical Trials in Progressive Multiple Sclerosis: Lessons Learned and Future Perspectives The Lancet. Neurology. Feb, 2015 | Pubmed ID: 25772899 Experience with Fingolimod in Clinical Practice The International Journal of Neuroscience. 2015 | Pubmed ID: 25271798 Identifying the Start of Multiple Sclerosis Injury: a Serial DTI Study Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. Nov-Dec, 2014 | Pubmed ID: 25370339 Risk Stratification and Mitigation Multiple Sclerosis Multiple Sclerosis and Related Disorders. Sep, 2014 | Pubmed ID: 25221744 Sensitivity to Volatile Anesthetics in Patients with Dementia: a Case-control Analysis Canadian Journal of Anaesthesia = Journal Canadien D'anesthesie. Jul, 2014 | Pubmed ID: 24764187 Is Neuromyelitis Optica with Advanced Age of Onset a Paraneoplastic Disorder? The International Journal of Neuroscience. Jul, 2014 | Pubmed ID: 24111490 Multiple Sclerosis Treatment: Risk Mitigation Continuum (Minneapolis, Minn.). Aug, 2013 | Pubmed ID: 23917104 Benefits Versus Risks of Latest Therapies in Multiple Sclerosis: a Perspective Review Therapeutic Advances in Drug Safety. Dec, 2012 | Pubmed ID: 25083243 Early Tolerability and Safety of Fingolimod in Clinical Practice Journal of the Neurological Sciences. Dec, 2012 | Pubmed ID: 23040960 Multiple Sclerosis: New Insights in Pathogenesis and Novel Therapeutics Annual Review of Medicine. 2012 | Pubmed ID: 21888515 Metabolic Syndrome in Small Fiber Sensory Neuropathy Journal of Clinical Neuromuscular Disease. Jun, 2011 | Pubmed ID: 22361523 Potential Mechanisms of Efficacy and Adverse Effects in the Use of Fingolimod (FTY720) Expert Review of Clinical Pharmacology. Sep, 2011 | Pubmed ID: 22114884 Intracranial Atherosclerosis As a Risk Factor for Ischemic Stroke During Open Heart Surgery Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. Jul-Aug, 2010 | Pubmed ID: 20471859 Management of Acute Exacerbations in Multiple Sclerosis Annals of Indian Academy of Neurology. Oct, 2009 | Pubmed ID: 20182574 שלאחר המוות תוכנית מקיפה עבור אנשים עם טרשת נפוצה Ranjan Dutta*1, Kedar R. Mahajan*1,3, Kunio Nakamura*3, Daniel Ontaneda*2, Jacqueline Chen1, Christina Volsko1, Jessica Dudman1, Emilie Christie1, Jordon Dunham1, Robert J. Fox3, Bruce D. Trapp1 1Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, 2Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, 3Mellen Center for Treatment and Research in Multiple Sclerosis, Neurological Institute, Cleveland Clinic JoVE 59511 Neuroscience
שלאחר המוות תוכנית מקיפה עבור אנשים עם טרשת נפוצה Ranjan Dutta*1, Kedar R. Mahajan*1,3, Kunio Nakamura*3, Daniel Ontaneda*2, Jacqueline Chen1, Christina Volsko1, Jessica Dudman1, Emilie Christie1, Jordon Dunham1, Robert J. Fox3, Bruce D. Trapp1 1Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, 2Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, 3Mellen Center for Treatment and Research in Multiple Sclerosis, Neurological Institute, Cleveland Clinic JoVE 59511 Neuroscience
